Moderna and Merck said on Tuesday their experimental personalized vaccine continued to cut the risk of death or recurrence of ...

Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...

A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin ...

Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...

The companies have an expansive clinical program for the mRNA neoantigen therapy intismeran autogene in combination with ...

What is the outlook for someone who has squamous cell carcinoma of the skin? The outlook is excellent when found early and properly treated. More than 90% of patients are cured. FDA-approved ...

Researchers at the University of Queensland are making significant strides toward developing a groundbreaking topical cream to prevent and treat skin cancers, specifically in organ transplant ...

Q: Is radiation a good treatment for my skin cancer? A: Skin cancer is the most common cancer in the U.S., affecting about 1 in 5 Americans. If you or someone you know has faced it, you're not alone.

Non-melanoma skin cancer includes BCC, SCC, and the rare MCC, with BCC being the most common and MCC the most aggressive. Diagnosis involves skin examination and biopsy, with additional tests for MCC ...

AI is transforming oncology by improving early detection, diagnosis, and treatment personalization through advanced data ...

Moderna and Merck said on Tuesday their experimental vaccine for a serious type of skin cancer, when used with Keytruda, ...